OpGen Inc. [NASDAQ: OPGN] price surged by 2.78 percent to reach at $0.06. The company report on July 15, 2020 that OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2020.
OpGen, Inc. (Nasdaq: OPGN)(“OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that total preliminary unaudited revenue for the second quarter of 2020 was approximately $1.2 million up from $1.0 million in the second quarter of 2019. The preliminary financial results for the three months ended June 30, 2020 reflect the consummation of our business combination with Curetis GmbH on April 1, 2020. The results for the six months ended June 30, 2020 will be included in the Company’s Quarterly Report on Form 10-Q and earnings release for the second quarter of 2020. Cash as of June 30, 2020 was approximately $12.8 million, an increase from the $11.5 million as of March 31, 2020.
The company also announced accomplishment of the following key milestones in the second quarter of 2020 and year to date:.
A sum of 1153461 shares traded at recent session while its average daily volume was at 1.52M shares. OpGen Inc. shares reached a high of $2.24 and dropped to a low of $2.155 until finishing in the latest session at $2.22.
Guru’s Opinion on OpGen Inc. [OPGN]:
Alliance Global Partners have made an estimate for OpGen Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 01, 2019. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $1 to $9. The new note on the price target was released on February 07, 2018, representing the official price target for OpGen Inc. stock. Previously, the target price had yet another raise to $2.50, while Rodman & Renshaw analysts kept a Buy rating on OPGN stock.
The Average True Range (ATR) for OpGen Inc. is set at 0.17, with the Price to Sales ratio for OPGN stock in the period of the last 12 months amounting to 11.31. The Price to Book ratio for the last quarter was 1.17, with the Price to Cash per share for the same quarter was set at 0.73.
OPGN Stock Performance Analysis:
OpGen Inc. [OPGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.71. With this latest performance, OPGN shares gained by 8.29% in over the last four-week period, additionally plugging by 23.33% over the last 6 months – not to mention a drop of -66.36% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OPGN stock in for the last two-week period is set at 54.22, with the RSI for the last a single of trading hit 54.32, and the three-weeks RSI is set at 52.93 for OpGen Inc. [OPGN]. The present Moving Average for the last 50 days of trading for this stock 2.08, while it was recorded at 2.19 for the last single week of trading, and 1.99 for the last 200 days.
Insight into OpGen Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and OpGen Inc. [OPGN] shares currently have an operating margin of -313.59 and a Gross Margin at +53.36. OpGen Inc.’s Net Margin is presently recorded at -355.75.
Return on Total Capital for OPGN is now -173.36, given the latest momentum, and Return on Invested Capital for the company is -251.71. Return on Equity for this stock declined to -327.45, with Return on Assets sitting at -128.50. When it comes to the capital structure of this company, OpGen Inc. [OPGN] has a Total Debt to Total Equity ratio set at 73.60. Additionally, OPGN Total Debt to Total Capital is recorded at 42.40, with Total Debt to Total Assets ending up at 30.32. Long-Term Debt to Equity for the company is recorded at 27.72, with the Long-Term Debt to Total Capital now at 15.97.
Reflecting on the efficiency of the workforce at the company, OpGen Inc. [OPGN] managed to generate an average of -$311,161 per employee. Receivables Turnover for the company is 2.02 with a Total Asset Turnover recorded at a value of 0.36.OpGen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.40 and a Current Ratio set at 3.50.
OPGN Stock EPS
With the latest financial reports released by the company, OpGen Inc. posted -3/share EPS, while the average EPS was predicted by analysts to be reported at -3.4/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 11.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OPGN.
OpGen Inc. [OPGN] Insider Position Details
There are presently around $1 million, or 5.80% of OPGN stock, in the hands of institutional investors. The top three institutional holders of OPGN stocks are: SUSQUEHANNA INTERNATIONAL GROUP, LLP with ownership of 75,256, which is approximately 120.311% of the company’s market cap and around 0.20% of the total institutional ownership; MILLENNIUM MANAGEMENT LLC, holding 71,698 shares of the stock with an approximate value of $0.16 million in OPGN stocks shares; and VIRTU FINANCIAL LLC, currently with $0.12 million in OPGN stock with ownership of nearly New of the company’s market capitalization.
Positions in OpGen Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 17 institutional holders increased their position in OpGen Inc. [NASDAQ:OPGN] by around 241,297 shares. Additionally, 7 investors decreased positions by around 144,087 shares, while 1 investors held positions by with 27,375 shares. The mentioned changes placed institutional holdings at 358,009 shares, according to the latest SEC report filing. OPGN stock had 14 new institutional investments in for a total of 187,809 shares, while 5 institutional investors sold positions of 109,486 shares during the same period.